The Commission should ensure that community legislation contains incentives for industries and researchers to secure ongoing research and guarantee new evidence-based medicines and treatments to combat and control cancer.
Arī tad, ja zāles, kas var glābt dzīvības, ir radītas, tās nereti nav pieejamas administratīvu procedūru vai augstās cenas dēļ.